CSIMarket


Bristol myers Squibb Company  (BMY)
Other Ticker:  
 

Bristol myers Squibb Company

BMY's Fundamental analysis








Looking into Bristol Myers Squibb growth rates, revenue grew by 5.19 % in I. Quarter 2022 from the same quarter a year ago. Ranking at No. 419

Major Pharmaceutical Preparations industry recorded growth of revenues by 19.45 %

Bristol Myers Squibb's net profit deacreased by -36.77 % in I. Quarter 2022 year on year, to $1,283 millions.

More on BMY's Growth


Bristol Myers Squibb
current PE on trailing twelve month basis is above Major Pharmaceutical Preparations industry average.

Bristol Myers Squibb PEG ratio is at -0.14 Company is currently trading with Price to Cash flow multiple of 133.53 in trailing twelve-month period.
Company
27.47
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 3.58.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 4.39.


More on BMY's Valuation
 
 Total Debt (Millions $) 44,972
 Dividend TTM ($) 2.02 $
 Dividend Yield TTM (%) 2.82 %
 Revenue/Employee (TTM) $ 1,552,397
 Net Income/Employee (TTM) $ 207,207
 Receivable Turnover (TTM) 5.2
 Tangible Book Value (Per Share $) -13.37

Bristol Myers Squibb
current PE on trailing twelve month basis is above Major Pharmaceutical Preparations industry average.

Bristol Myers Squibb PEG ratio is at -0.14 Company is currently trading with Price to Cash flow multiple of 133.53 in trailing twelve-month period.
Company
27.47
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 3.58.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 4.39.

Bristol Myers Squibb Price to Book Ratio is at 5.31 lower than Indusry Avg. of 1306.83. and higher than S&P 500 Avg. of -0.01

More on BMY's Valuation

  Market Capitalization (Millions $) 167,981
  Shares Outstanding (Millions) 2,166
  Employees 30,250
  Revenues (TTM) (Millions $) 46,960
  Net Income (TTM) (Millions $) 6,268
  Cash Flow (TTM) (Millions $) 1,258
  Capital Exp. (TTM) (Millions $) -1,053
  Total Debt (Millions $) 44,972
  Dividend TTM ($) 2.02 $
  Dividend Yield TTM (%) 2.82 %
  Revenue/Employee (TTM) $ 1,552,397
  Net Income/Employee(TTM) $ 207,207
  Receivable Turnover Ratio (TTM) 5.2
  Tangible Book Value (Per Share $) -13.37

  Market Capitalization (Millions $) 167,981
  Shares Outstanding (Millions) 2,166
  Employees 30,250
  Revenues (TTM) (Millions $) 46,960
  Net Income (TTM) (Millions $) 6,268
  Cash Flow (TTM) (Millions $) 1,258
  Capital Exp. (TTM) (Millions $) -1,053


    BMY's Profitability Comparisons
Bristol Myers Squibb achieved increase in profitability, due to cost control. Operating Margin grew in I. Quarter 2022 to 20.05 % from 18.78 % in IV. Quarter.

Bristol Myers Squibb net profit margin of 11.01 % is currently ranking no. 34 in Major Pharmaceutical Preparations industry, ranking no. 96 in Healthcare sector and number 1319 in S&P 500.


Profitability by Segment
Total Pharmaceuticals 17.94 %



  Ratio
   Capital Ratio (MRQ) 1.32
  Total Debt to Equity (MRQ) 1.42
  Tangible Leverage Ratio (MRQ) -
  Asset Turnover Ratio (TTM) 0.43
  Inventory Turnover Ratio (TTM) 4.5



Bristol Myers Squibb achieved increase in profitability, due to cost control. Operating Margin grew in I. Quarter 2022 to 20.05 % from 18.78 % in IV. Quarter.

Bristol Myers Squibb net profit margin of 11.01 % is currently ranking no. 34 in Major Pharmaceutical Preparations industry, ranking no. 96 in Healthcare sector and number 1319 in S&P 500.

More on BMY's Key Ratios



       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

CWBR's Profile

Stock Price

CWBR's Financials

Business Description

Fundamentals

Charts & Quotes

CWBR's News

Suppliers

CWBR's Competitors

Customers & Markets

Economic Indicators

CWBR's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071